Nanotheragnostic Applications for Ischemic and Hemorrhagic Strokes: Improved Delivery for a Better Prognosis

Current Neurology and Neuroscience Reports

Volumn 15, Issue 1, 2015, Pages

  Mouhieddine, Tarek H ^a   Itani, Muhieddine M ^b   Nokkari, Amaly ^a   Ren, Changhong ^c,d   Daoud, Georges ^a   Zeidan, Asad ^a   Mondello, Stefania ^e   Kobeissy, Firas H ^a,f  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Xuanwu Banyan Biomarker Research and Assay Center   (China)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarkers; Drug delivery; Imaging; Nanoparticles; Neuroprotection; Stroke

Indexed keywords

BIOLOGICAL MARKER; BRAIN PENETRATING NANOPARTICLE; CATIONIC BOVINE SERUM ALBUMIN CONJUGATED TANSHINONE IIA PEGYLATED NANOPARTICLE; CURCUMIN; DERMORPHIN; ERYTHROPOIETIN; GOLD NANOPARTICLE; IRON OXIDE; LIOTHYRONINE; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; NANOCOATING; NANOPARTICLE; PEGYLATED LIPID NANOPARTICLE; POLY(BUTYLCYANOACRYLATE) NANOPARTICLE; POLYMER; POLYMERIC N ISOPROPYL ACRYL AMIDE NANOPARTICLE; POLYSORBATE 80; PUERARIN; QUERCETIN; SHORT HAIRPIN RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TANSHINONE IIA; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; HUMAN; NANOENCAPSULATION; NANOMEDICINE; NANOTHERAGNOSTIC; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PROGNOSIS; REVIEW; ANIMAL; DIAGNOSTIC USE; INTRACRANIAL HEMORRHAGES; PATHOLOGY; PATHOPHYSIOLOGY; STROKE;

ANIMALS; BRAIN ISCHEMIA; DRUG DELIVERY SYSTEMS; HUMANS; INTRACRANIAL HEMORRHAGES; NANOPARTICLES; NEUROPROTECTIVE AGENTS; PROGNOSIS; STROKE;

EID: 84937142768     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-014-0505-1     Document Type: Review

References (139)

1. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345–54.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–e146.
3. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–54.
4. Eltzschig HK, Eckle T. Ischemia and reperfusion—from mechanism to translation. Nat Med. 2011;17(11):1391–401.
5. Emiru T, Bershad EM, Zantek ND, Datta YH, Rao GH, Hartley EW, et al. Intracerebral hemorrhage: a review of coagulation function. Clin Appl Thromb Hemost Off J Int Acad Clin Appl Thromb Hemost. 2013;19(6):652–62.
6. Al-Shahi Salman R, Labovitz DL, Stapf C. Spontaneous intracerebral haemorrhage. BMJ (Clin Res ed). 2009;339:b2586.
7. Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol. 2013;9(3):152–63.
8. Maniyar FH, Goadsby PJ. Brain hemorrhage: clinical high-risk factors for subarachnoid hemorrhage. Nat Rev Neurol. 2011;7(3):134–5.
9. Brazzelli M, Sandercock PA, Chappell FM, Celani MG, Righetti E, Arestis N, et al. Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in patients presenting with stroke symptoms. Cochrane Database Syst Rev. 2009;(4):Cd007424.
10. Smajlovic D, Sinanovic O. Sensitivity of the neuroimaging techniques in ischemic stroke. Med Arh. 2004;58(5):282–4.
11. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293–8.
12. Latchaw RE, Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT, et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke J Cereb Circ. 2009;40(11):3646–78.
13. Merino JG, Warach S. Imaging of acute stroke. Nat Rev Neurol. 2010;6(10):560–71.
14. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet. 2003;362(9391):1211–24.
15. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–85.
16. Essig M, Dinkel J, Gutierrez JE. Use of contrast media in neuroimaging. Magn Reson Imaging Clin N Am. 2012;20(4):633–48.
17. Sasaki Y, Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem Rec (New York, NY). 2010;10(6):366–76.
18. Kobeissy FH, Gulbakan B, Alawieh A, Karam P, Zhang Z, Guingab-Cagmat JD, et al. Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences. Omics J Integr Biol. 2014;18(2):111–31.
19. Giri K, Shameer K, Zimmermann MT, Saha S, Chakraborty PK, Sharma A, et al. Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem. 2014;25(6):1078–90.
20. Tsai N, Lee B, Kim A, Yang R, Pan R, Lee DK, et al. Nanomedicine for global health. J Lab Autom. 2014. doi:10.1177/2211068214538263.
21. Whiteley W, Tseng MC, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke J Cereb Circ. 2008;39(10):2902–9.
22. Kim TH, Lee S, Chen X. Nanotheranostics for personalized medicine. Expert Rev Mol Diagn. 2013;13(3):257–69.
23. An S, Kuang Y, Shen T, Li J, Ma H, Guo Y, et al. Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury. Biomaterials. 2013;34(35):8949–59. An et al. showed that shRNA could be delivered efficiently to the brain, when bound to nanoparticles, and they would suppress apoptosis and infarction.
24. Hyun H, Lee K, Min KH, Jeon P, Kim K, Jeong SY, et al. Ischemic brain imaging using fluorescent gold nanoprobes sensitive to reactive oxygen species. J Control Release Off J Control Release Soc. 2013;170(3):352–7. Hyun et al. showed that hyaluronic acid labelled nanoparticles are able to accumulate in ischemic regions and detect ROS production and thus provide a more accurate identification of ischemic regions.
25. Ishii T, Fukuta T, Agato Y, Oyama D, Yasuda N, Shimizu K, et al. (2013) Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced. Biochemical and Biophysical Research Cummunications 430:1201–5.
26. Kim DE, Kim JY, Sun IC, Schellingerhout D, Lee SK, Ahn CH, et al. Hyperacute direct thrombus imaging using computed tomography and gold nanoparticles. Ann Neurol. 2013;73(5):617–25. Kim et al. demonstrated that through gold nanoparticles, they are able to image thrombi and monitor their evolution and increase the efficiency of administering thrombolytic therapies.
27. Lin KY, Kwong GA, Warren AD, Wood DK, Bhatia SN. Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano. 2013;7(10):9001–9. Lin et al. provided a biomarker for thrombus formation via administering nanoparticles conjugated to thrombin-sensitive peptides which would break off and appear in the blood and urine as biomarkers for thrombus formation.
28. Liu X, An C, Jin P, Liu X, Wang L. Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia. Biomaterials. 2013;34(3):817–30.
29. Lu YM, Huang JY, Wang H, Lou XF, Liao MH, Hong LJ, et al. Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles. Biomaterials. 2014;35(1):530–7. Lu et al. showed that nanoparticles conjugated to Fas ligand are more efficient in entering the brain across the blood brain barrier and delivering the drug 3-n-butylphthalide, which had neuroprotective effects.
30. Marinescu M, Chauveau F, Durand A, Riou A, Cho TH, Dencausse A, et al. Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI. Eur Radiol. 2013;23(1):37–47.
31. Marinescu M, Langer M, Durand A, Olivier C, Chabrol A, Rositi H, et al. Synchrotron radiation X-ray phase micro-computed tomography as a new method to detect iron oxide nanoparticles in the brain. Mol Imaging Biol MIB Off Publ Acad Mol Imaging. 2013;15(5):552–9. Marinescue et al. showed that SR-PCT is superior to MRI in detecting macrophages containing USPIOs and thus better imaging and detection of infarcted areas.
32. Mdzinarishvili A, Sutariya V, Talasila PK, Geldenhuys WJ, Sadana P. Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke. Drug Deliv Transl Res. 2013;3(4):309–17.
33. Rahmer J, Antonelli A, Sfara C, Tiemann B, Gleich B, Magnani M, et al. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection. Phys Med Biol. 2013;58(12):3965–77. Rahmer et al. showed that RBCs could be impregnated with USPIOs which would allow them to vissualise vessels in a 3D structure and detect any hemorrhage.
34. Riegler J, Liew A, Hynes SO, Ortega D, O'Brien T, Day RM, et al. (2013) Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury. Biomaterials 34:1987–94.
35. Wang Y, Cooke MJ, Sachewsky N, Morshead CM, Shoichet MS. Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke. J Control Release Off J Control Release Soc. 2013;172(1):1–11. Wang et al. were successful in using a hydrogel with nanoparticles containing EGF and EPO for suppression of inflammation and induction of neurogenesis when injected 4 days following stroke.
36. Wen X, Wang Y, Zhang F, Zhang X, Lu L, Shuai X, et al. In vivo monitoring of neural stem cells after transplantation in acute cerebral infarction with dual-modal MR imaging and optical imaging. Biomaterials. 2014;35(16):4627–35. Wen et al. demonstrated the ability to monitor grafted neural stem cells, labelled with polymerosomes, as they migrate and proliferate to the site of injury.
37. Zhao LX, Liu AC, Yu SW, Wang ZX, Lin XQ, Zhai GX, et al. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. Biol Pharm Bull. 2013;36(8):1263–70.
38. Huang HC, Barua S, Sharma G, Dey SK, Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Release Off J Control Release Soc. 2011;155(3):344–57.
39. Klostergaard J, Seeney CE. Magnetic nanovectors for drug delivery. Nanomedicine Nanotechnol Biol Med. 2012;8 Suppl 1:S37–50.
40. Owens 3rd DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102.
41. van der Zee J. Heating the patient: a promising approach? Ann Oncol Off J Eur Soc Med Oncol ESMO. 2002;13(8):1173–84.
42. Mody VV, Siwale R, Singh A, Mody HR. Introduction to metallic nanoparticles. J Pharm Bioallied Sci. 2010;2(4):282–9.
43. Murphy CJ, Sau TK, Gole AM, Orendorff CJ, Gao J, Gou L, et al. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J Phys Chem B. 2005;109(29):13857–70.
44. Link S, Mohamed MB, El-Sayed MA. Simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J Phys Chem. 1999;103(16):3073–7.
45. Alivisatos AP, Johnsson KP, Peng X, Wilson TE, Loweth CJ, Bruchez Jr MP, et al. Organization of ‘nanocrystal molecules’ using DNA. Nature. 1996;382(6592):609–11.
46. El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005;5(5):829–34.
47. Qin Y. Silver-containing alginate fibres and dressings. Int Wound J. 2005;2(2):172–6.
48. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns J Int Soc Burn Injuries. 2007;33(2):139–48.
49. Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol. 2006;33:17–34.
50. Schultz S, Smith DR, Mock JJ, Schultz DA. Single-target molecule detection with nonbleaching multicolor optical immunolabels. Proc Natl Acad Sci U S A. 2000;97(3):996–1001.
51. Stepanov AL, Popok VN, Hole DE. Formation of metallic nanoparticles in silicate glass through ion implantation. Glas Phys Chem. 2002;28(2):90–5.
52. Oldenburg S, Averitt R, Westcott S, Halas N. Nanoengineering of optical resonances. Chem Phys Lett. 1998;288:243–7.
53. Prodan E, Lee A, Nordlander P. The effect of a dielectric core and embedding medium on the polarizability of metallic nanoshells. Chem Phys Lett. 2002;360:325–32.
54. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A. 2003;100(23):13549–54.
55. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263(5153):1600–3.
56. Krishna R, Shivakumar H, Gowda D, Banerjee S. Nanoparticles: a novel colloidal drug delivery system. Indian J Educ Res. 2006;40:15–21.
57. Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59(7):631–44.
58. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release Off J Control Release Soc. 1999;57(2):171–85.
59. Teeranachaideekul V, Junyaprasert VB, Souto EB, Muller RH. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm. 2008;354(1–2):227–34.
60. Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharm. 2008;349(1–2):249–55.
61. Singh S, Muthu MS. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine (Lond). 2007;2(2):233–40.
62. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release Off J Control Release Soc. 2007;119(1):77–85.
63. Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem. 2006;97(6):1184–90.
64. Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev. 2004;104(1):293–346.
65. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP, et al. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology. 2010;256(3):774–82.
66. Sun IC, Eun DK, Koo H, Ko CY, Kim HS, Yi DK, et al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew Chem Int Ed Engl. 2011;50(40):9348–51.
67. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79(939):248–53.
68. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325–7.
69. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal. 2008;10(8):1343–74.
70. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2001;21(1):2–14.
71. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399–415.
72. Lee H, Lee K, Kim IK, Park TG. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials. 2008;29(35):4709–18.
73. Lee K, Lee H, Lee KW, Park TG. Optical imaging of intracellular reactive oxygen species for the assessment of the cytotoxicity of nanoparticles. Biomaterials. 2011;32(10):2556–65.
74. Mannhalter C. Biomarkers for arterial and venous thrombotic disorders. Hamostaseologie. 2014;34(2):115–20. 122–116, 128–130, passim.
75. Pantoni L, Fierini F, Poggesi A. Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis. 2014;37(1):5–13.
76. Rother J, Ford GA, Thijs VN. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities. Cerebrovasc Dis. 2013;35(4):313–9.
77. Ginsberg JS, Wells PS, Kearon C, Anderson D, Crowther M, Weitz JI, et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med. 1998;129(12):1006–11.
78. Davie EW, Kulman JD. An overview of the structure and function of thrombin. Semin Thromb Hemost. 2006;32 Suppl 1:3–15.
79. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808.
80. Stoll G, Bendszus M. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience. 2009;158(3):1151–60.
81. Desestret V, Brisset JC, Moucharrafie S, Devillard E, Nataf S, Honnorat J, et al. Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice. Stroke J Cereb Circ. 2009;40(5):1834–41.
82. Chauveau F, Moucharrafie S, Wiart M, Brisset JC, Berthezene Y, Nighoghossian N, et al. In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure. Exp Transl Stroke Med. 2010;2(1):4.
83. Antonelli A, Sfara C, Manuali E, Bruce IJ, Magnani M. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. Nanomedicine (Lond). 2011;6(2):211–23.
84. Antonelli A, Sfara C, Mosca L, Manuali E, Magnani M. New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles. J Nanosci Nanotechnol. 2008;8(5):2270–8.
85. Farr TD, Lai CH, Grunstein D, Orts-Gil G, Wang CC, Boehm-Sturm P, et al. Imaging early endothelial inflammation following stroke by core shell silica superparamagnetic glyconanoparticles that target selectin. Nano Lett. 2014;14(4):2130–4.
86. Yilmaz G, Granger DN. Cell adhesion molecules and ischemic stroke. Neurol Res. 2008;30(8):783–93.
87. Dmitriev RI, Borisov SM, Kondrashina AV, Pakan JM, Anilkumar U, Prehn JH, et al. Imaging oxygen in neural cell and tissue models by means of anionic cell-permeable phosphorescent nanoparticles. Cell Mol Life Scie CMLS. 2014. doi:10.1007/s00018-014-1673-5.
88. Erecinska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol. 2001;128(3):263–76.
89. Obermeyer AC, Capehart SL, Jarman JB, Francis MB. Multivalent viral capsids with internal cargo for fibrin imaging. PLoS One. 2014;9(6):e100678.
90. McCarthy JR, Jaffer FA. The role of nanomedicine in the imaging and therapy of thrombosis. Nanomedicine. 2011;6(8):1291–3.
91. Ding DC, Shyu WC, Lin SZ, Li H. Current concepts in adult stem cell therapy for stroke. Curr Med Chem. 2006;13(29):3565–74.
92. Darkazalli A, Levenson CW. Tracking stem cell migration and survival in brain injury: current approaches and future prospects. Histol Histopathol. 2012;27(10):1255–61.
93. Lee JS, Feijen J. Polymersomes for drug delivery: design, formation and characterization. J Control Release Off J Control Release Soc. 2012;161(2):473–83.
94. Liu H, Cao J, Zhang H, Qin S, Yu M, Zhang X, et al. Folic acid stimulates proliferation of transplanted neural stem cells after focal cerebral ischemia in rats. J Nutr Biochem. 2013;24(11):1817–22.
95. Yeung DK, Leung SW, Xu YC, Vanhoutte PM, Man RY. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 2006;552(1–3):105–11.
96. Gao L, Ji X, Song J, Liu P, Yan F, Gong W, et al. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. Neurol Res. 2009;31(4):402–6.
97. Zhang W, Liu CQ, Wang PW, Sun SY, Su WJ, Zhang HJ, et al. Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. Eur J Pharmacol. 2010;649(1–3):398–402.
98. Wang CX, Huang LS, Hou LB, Jiang L, Yan ZT, Wang YL, et al. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model. Brain Res. 2009;1261:91–9.
99. Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s disease. Brain Res. 2008;1200:159–68.
100. Hatai T, Matsuzawa A, Inoshita S, Mochida Y, Kuroda T, Sakamaki K, et al. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem. 2000;275(34):26576–81.
101. Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science. 1998;281(5384):1860–3.
102. Singh S, Narang AS, Mahato RI. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharm Res. 2011;28(12):2996–3015.
103. Tang C, Xue H, Bai C, Fu R, Wu A. The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine Int J Phytother Phytopharmacology. 2010;17(14):1145–9.
104. Liu X, Ye M, An C, Pan L, Ji L. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia. Biomaterials. 2013;34(28):6893–905.
105. Lu YM, Tao RR, Huang JY, Li LT, Liao MH, Li XM, et al. P2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand. J Neuroinflammation. 2012;9:172.
106. Nance E, Timbie K, Miller GW, Song J, Louttit C, Klibanov AL, et al. Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. J Control Release Off J Control Release Soc. 2014;189:123–32.
107. Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004;74(8):969–85.
108. Tyagi N, Qipshidze N, Munjal C, Vacek JC, Metreveli N, Givvimani S, et al. Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in hyperhomocysteinemia mice after cerebral ischemia. J Mol Neurosci MN. 2012;47(1):128–38.
109. Wang Q, Sun AY, Simonyi A, Jensen MD, Shelat PB, Rottinghaus GE, et al. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res. 2005;82(1):138–48.
110. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther J Am Soc Gene Ther. 2011;19(10):1769–79.
111. Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/beta-catenin pathway. ACS Nano. 2014;8(1):76–103.
112. Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther J Am Soc Gene Ther. 2010;18(9):1606–14.
113. Kalani A, Kamat PK, Kalani K, Tyagi N. Epigenetic impact of curcumin on stroke prevention. Metab Brain Dis. 2014. doi:10.1007/s11011-014-9537-0.
114. Ahmad N, Umar S, Ashafaq M, Akhtar M, Iqbal Z, Samim M, et al. A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke. Protoplasma. 2013;250(6):1327–38.
115. Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009;379(1):146–57.
116. Singhal A, Morris VB, Labhasetwar V, Ghorpade A. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 2013;4:e903.
117. Jaffer H, Morris VB, Stewart D, Labhasetwar V. Advances in stroke therapy. Drug Deliv Transl Res. 2011;1(6):409–19.
118. Dringen R, Pawlowski PG, Hirrlinger J. Peroxide detoxification by brain cells. J Neurosci Res. 2005;79(1–2):157–65.
119. Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. Cell culture models of oxidative stress and injury in the central nervous system. Curr Neurovasc Res. 2005;2(1):73–89.
120. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic Res. 1999;31(4):261–72.
121. Chrissobolis S, Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med. 2008;14(11):495–502.
122. Brouns R, De Deyn PP. The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg. 2009;111(6):483–95.
123. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 1990;186:343–55.
124. Ghosh A, Sarkar S, Mandal AK, Das N. Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats. PLoS One. 2013;8(4):e57735.
125. Lee JC, Kim J, Park JK, Chung GH, Jang YS. The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Exp Cell Res. 2003;291(2):386–97.
126. Wang Y, Cooke MJ, Lapitsky Y, Wylie RG, Sachewsky N, Corbett D, et al. Transport of epidermal growth factor in the stroke-injured brain. J Control Release Off J Control Release Soc. 2011;149(3):225–35.
127. Wang Y, Cooke MJ, Morshead CM, Shoichet MS. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials. 2012;33(9):2681–92.
128. Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials. 2006;27(11):2370–9.
129. Felling RJ, Levison SW. Enhanced neurogenesis following stroke. J Neurosci Res. 2003;73(3):277–83.
130. Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, et al. CNS drug delivery systems: novel approaches. Recent Patents Drug Deliv Formulation. 2009;3(1):71–89.
131. Kolb B, Morshead C, Gonzalez C, Kim M, Gregg C, Shingo T, et al. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2007;27(5):983–97.
132. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine (Lond). 2007;2(1):23–39.
133. Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobiosci. 2004;3(1):66–73.
134. Gupta AK, Curtis AS. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med. 2004;15(4):493–6.
135. Pan CH, Liu WT, Bien MY, Lin IC, Hsiao TC, Ma CM, et al. Effects of size and surface of zinc oxide and aluminum-doped zinc oxide nanoparticles on cell viability inferred by proteomic analyses. Int J Nanomedicine. 2014;9:3631–43.
136. Zhang B, Choi JJ, Eum SY, Daunert S, Toborek M. TLR4 signaling is involved in brain vascular toxicity of PCB153 bound to nanoparticles. PLoS ONE. 2013;8(5).
137. Xu L, Shi C, Shao A, Li X, Cheng X, Ding R, et al. Toxic responses in rat embryonic cells to silver nanoparticles and released silver ions as analyzed via gene expression profiles and transmission electron microscopy. Nanotoxicology. 2014;14:1–10.
138. Hassankhani R, Esmaeillou M, Tehrani AA, Nasirzadeh K, Khadir F, Maadi H. In vivo toxicity of orally administrated silicon dioxide nanoparticles in healthy adult mice. Environ Sci Pollut Res Int. 2014. doi:10.1007/s11356-014-3413-7.
139. Harms C, Datwyler AL, Wiekhorst F, Trahms L, Lindquist R, Schellenberger E, et al. Certain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to stroke. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2013;33(5):e1–9.